IL6 and cancer: The overall level of IL-6 (Figure 7E) in Omicron-infected cancer patients was higher than that in Omicron-infected non-cancer-afflicted subjects, with a decreasing trend at the early stage; however, IL-6 in non-cancer-afflicted subjects was kept at a low level and had no obvious changes in the whole process of Omicron infection.